Literature DB >> 30734436

Clinical features, predictors, and long-term prognosis of pacing-induced cardiomyopathy.

Sung Woo Cho1, Hye Bin Gwag2, Jin Kyung Hwang3, Kwang Jin Chun4, Kyoung-Min Park2, Young Keun On2, June Soo Kim2, Seung-Jung Park2.   

Abstract

AIMS: We investigated the clinical features, predictors, and long-term prognosis of pacing-induced cardiomyopathy (PiCM). METHODS AND
RESULTS: From a retrospective analysis of 1418 consecutive pacemaker patients, 618 were found to have a preserved baseline left ventricular ejection fraction (LVEF), follow-up echocardiographic data, and no history of heart failure (HF). PiCM was defined as a reduction in LVEF (< 50%) along with either (i) a ≥ 10% decrease in LVEF, or (ii) new-onset regional wall motion abnormality unrelated to coronary artery disease. PiCM occurred in 87 of 618 patients (14.1%), with a decrease in mean LVEF from 60.5% to 40.1%. The median time to PiCM was 4.7 years. Baseline left bundle branch block, wider paced QRS duration (≥ 155 ms), and higher ventricular pacing percentage (≥ 86%) were identified as independent predictors of PiCM in multivariate logistic regression analysis. The risk of PiCM increased gradually with the number of identified predictors, becoming more significant in the presence of two or more predictors (P < 0.001). During the entire follow-up (median 7.2 years), the risk of all-cause death or HF admission was significantly higher in patients with PiCM compared to those without PiCM (38.3% vs. 54.0%, adjusted hazard ratio 2.93; 95% confidence interval 1.82-4.72; P < 0.001).
CONCLUSION: Pacing-induced cardiomyopathy patients showed a worse long-term prognosis than those without PiCM. Therefore, patients with multiple risk factors of PiCM should be monitored carefully even if their left ventricular systolic function is preserved initially. A timely upgrade to a biventricular or His-bundle pacing device needs to be considered in patients with PiCM.
© 2019 The Authors. European Journal of Heart Failure © 2019 European Society of Cardiology.

Entities:  

Keywords:  Cardiomyopathy; Heart failure; Pacemaker; Prognosis; Risk factor

Mesh:

Year:  2019        PMID: 30734436     DOI: 10.1002/ejhf.1427

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  5 in total

1.  Initial Experience with Left Bundle Branch Area Pacing with Conventional Stylet-Driven Extendable Screw-In Leads and New Pre-Shaped Delivery Sheaths.

Authors:  Kyeongmin Byeon; Hye Ree Kim; Seung-Jung Park; Young Jun Park; Ji-Hoon Choi; Ju Youn Kim; Kyoung-Min Park; Young Keun On; June Soo Kim
Journal:  J Clin Med       Date:  2022-04-28       Impact factor: 4.964

2.  Predictors of Pacemaker-Induced Cardiomyopathy and Importance of Nutritional Status and Prognostic Nutritional Index.

Authors:  Mehmet Balli; Mustafa Çetin; Fatma Koksal; Fazilet Erturk Sag; Fahrettin Katkat; Esra Erturk Tekin; Bahar Aydinli; Veysel Kutay Vurgun
Journal:  Acta Cardiol Sin       Date:  2022-03       Impact factor: 2.672

3.  Ventricular Synchrony in Para-Hisian Cardiac Pacing as an Alternative for Physiological Cardiac Activation (Indirect Recruitment of the His Bundle?).

Authors:  Andres Di Leoni Ferrari; Guilherme Ferreira Gazzoni; Luis Manuel Ley Domingues; Jessica Caroline Feltrin Willes; Gustavo Chiari Cabral; Flavio Vinicius Costa Ferreira; Laura Orlandini Lodi; Gustavo Reis
Journal:  Arq Bras Cardiol       Date:  2022-02       Impact factor: 2.000

4.  The usefulness of proximal anchor balloon technique during implantation of a cardiac resynchronization therapy device in a patient with complex coronary venous anatomy: a case report.

Authors:  Ravindra Bhardwaj; Amit Chaurasia; Nipun Mahajan; Harvinder Dod; Kuldeep Arora
Journal:  BMC Cardiovasc Disord       Date:  2022-02-05       Impact factor: 2.298

Review 5.  The electrocardiogram characteristics and pacing parameters of permanent left bundle branch pacing: a systematic review and meta-analysis.

Authors:  Jia Gao; Bing-Hang Zhang; Nan Zhang; Meng Sun; Rui Wang
Journal:  J Interv Card Electrophysiol       Date:  2021-06-26       Impact factor: 1.900

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.